To study pain relieving effect of two medicine ropivacaine and dexamethasone after gall bladder removal.

Phase 2

Recruiting

• Conditions: HEALTHY

• Registration Number: CTRI/2017/08/009340
• Lead Sponsor: Pt BDSharma PGIMS ROHTAK

Brief Summary

This study is a randomized, double blind, parallel group, trail comparing the postoperative analgesic efficacy of 18ml of 0.75% ropivacaine with 2ml of normal saline with 18 ml of o.75% ropivacaine with 2 ml of dexamethasone for TAP block in open cholecystectomy over 60 patients of ASA grade 1-3. The primary outcome will be 24 hr tramadol cosumption. The secondary outcome will be measure include VAS score, nausea score, sedation score and any side effect.

Detailed Description

Not available

Study Timeline

• Study Start: 2016-01-13
• Last Update Posted: 2017-09-08

Recruitment & Eligibility

• Status: Open to Recruitment
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

ASA Grade 1-3.

Exclusion Criteria

1.Contraindication to regional anaesthesia 2.History of local anaesthetic allergy 3.Psychiatric disorder 4.BMI>35kg/sq.m 5.Diabetes Mellitus 6.Chronic opioid use 7.Patient refusal.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
twenty four hours Tramadol consumption	postoperative twenty four hours

Secondary Outcome Measures

Name	Time	Method
Time to first request for analgesic, VAS Score,Nausea Score, Sedation Score, Any side effect	24 Hours

Trial Locations

Locations (1)

PGIMS ROHTAK; 🇮🇳 Rohtak, HARYANA, India

PGIMS ROHTAK

🇮🇳Rohtak, HARYANA, India

Dr SHASHI KIRAN

Principal investigator

9416763899

drshashi64@rediff.com